Pere Mirabent-Carbonell

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Journal: Neurology

Published: August 20, 2026

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Journal: Annals of neurology

Published: September 01, 2025

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Journal: Brain : a journal of neurology

Published: July 08, 2025

Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?

Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 30, 2025

Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage.

Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage.

Journal: European journal of neurology

Published: February 18, 2025

Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort.

Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 05, 2025

Age-Related Disability Outcomes After a First Demyelinating Event.

Age-Related Disability Outcomes After a First Demyelinating Event.

Journal: Neurology

Published: February 04, 2025

Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 29, 2025

Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS.

Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS.

Journal: Neurology

Published: January 17, 2025

The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study.

The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study.

Journal: The Lancet regional health. Europe

Published: December 17, 2024

Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.

Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.

Journal: Neurology

Published: December 12, 2024

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.

Journal: Journal of neurology

Published: September 09, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026